A randomized placebo-controlled trial of d-cycloserine to enhance exposure therapy for posttraumatic stress disorder

Biological Psychiatry

Volumn 71, Issue 11, 2012, Pages 962-968

  De Kleine, Rianne A ^a,b   Hendriks, Gert Jan ^a,b,c,d   Kusters, Wendy J C ^a,c   Broekman, Theo G ^e   Van Minnen, Agnes ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b Center for Anxiety Disorders Overwaal   (Netherlands)

^c Hendriks and Roosenboom   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Bureau Bêta Nijmegen   (Netherlands)

Author keywords

Cognitive behavioral therapy; cognitive enhancers; d cycloserine; posttraumatic stress disorder; prolonged exposure; treatment efficacy

Indexed keywords

CYCLOSERINE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIMETABOLITES; COMBINED MODALITY THERAPY; CYCLOSERINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMPLOSIVE THERAPY; MALE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 84861096785     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.02.033     Document Type: Article

References (47)

1. R.C. Kessler, A. Sonnega, E. Bromet, M. Hughes, C.B. Nelson Posttraumatic stress disorder in the national comorbidity survey Arch Gen Psychiatry 52 1995 1048 1060
2. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas, E.E. Walters Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication Arch Gen Psychiatry 62 2005 593 602 (Pubitemid 40973434)
3. M.B. Powers, J.M. Halpern, M.P. Ferenschak, S.J. Gillihan, E.B. Foa A meta-analytic review of prolonged exposure for posttraumatic stress disorder Clin Psychol Rev 30 2010 635 641
4. E.B. Foa, T.M. Keane, M.J. Friedman, J.A. Cohen Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies (2nd ed.) 2009 Guilford Press New York
5. Nice Post-Traumatic Stress Disorder (PTSD): The Management of PTSD in Adults and Children in Primary and Secondary Care 2005 National Institute for Clinical Excellence London
6. E.B. Foa, B.O. Rothbaum Treating the Trauma of Rape: Cognitive-Behavioral Therapy for PTSD 1998 Guilford Press New York
7. P.P. Schnurr, M.J. Friedman, C.C. Engel, E.B. Foa, M. Shea, B.K. Chow Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial JAMA 297 2007 820 830 (Pubitemid 46333947)
8. R. Bradley, J. Greene, E. Russ, L. Dutra, D. Westen A multidimensional meta-analysis of psychotherapy for PTSD Am J Psychiatry 162 2005 214 227 (Pubitemid 40216198)
9. J. Bisson, M. Andrew Psychological treatment of post-traumatic stress disorder (PTSD) Cochrane Database Syst Rev 18 2 2005 CD003388
10. E.A. Hembree, E.B. Foa, N.M. Dorfan, G.P. Street, J. Kowalski, X. Tu Do patients drop out prematurely from exposure therapy for PTSD? J Trauma Stress 16 2003 555 562 (Pubitemid 37541825)
11. N.M. Simon, K.M. Connor, A.J. Lang, SaM Rauch, S. Krulewicz, R.T. Lebeau Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy J Clin Psychiatry 69 2008 400 405 (Pubitemid 351549392)
12. M.M. Norberg, J.H. Krystal, D.F. Tolin A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy Biol Psychiatry 63 2008 1118 1126
13. R. Richardson, L. Ledgerwood, J. Cranney Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications Learn Mem 11 2004 510 516 (Pubitemid 39299697)
14. D.L. Walker, K.J. Ressler, K.T. Lu, M. Davis Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats J Neurosci 22 2002 2343 2351 (Pubitemid 35386533)
15. K.J. Ressler, B.O. Rothbaum, L. Tannenbaum, P. Anderson, K. Graap, E. Zimand Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear Arch Gen Psychiatry 61 2004 1136 1144 (Pubitemid 39463415)
16. S.G. Hofmann, A.E. Meuret, JaJ. Smits, N.M. Simon, M.H. Pollack, K. Eisenmenger Augmentation of exposure therapy with D-cycloserine for social anxiety disorder Arch Gen Psychiatry 63 2006 298 304 (Pubitemid 43345354)
17. A.J. Guastella, R. Richardson, P.F. Lovibond, R.M. Rapee, J.E. Gaston, P. Mitchell A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder Biol Psychiatry 63 2008 544 549
18. M.W. Otto, D.F. Tolin, N.M. Simon, G.D. Pearlson, S. Basden, S.A. Meunier Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder Biol Psychiatry 67 2010 365 370
19. A. Siegmund, F. Golfels, C. Finck, A. Halisch, D. Räth, J. Plag D-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial J Psychiatr Res 45 2011 1042 1047
20. S. Wilhelm, U. Buhlmann, D.F. Tolin, S.A. Meunier, G.D. Pearlson, H.E. Reese Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder Am J Psychiatry 165 2008 335 341 (Pubitemid 351704489)
21. E.A. Storch, L.J. Merlo, M. Bengtson, T.K. Murphy, M.H. Lewis, M.C. Yang D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder Int Clin Psychopharmacol 22 2007 230 237 (Pubitemid 46801947)
22. M. Kushner, S. Kim, C. Donahue, P. Thuras, D. Adson, M. Kotlyar D-Cycloserine augmented exposure therapy for obsessive-compulsive disorder Biol Psychiatry 62 2007 835 838 (Pubitemid 47488217)
23. S. Yamamoto, S. Morinobu, M. Fuchikami, A. Kurata, T. Kozuru, S. Yamawaki Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD Neuropsychopharmacology 33 2007 2108 2116 (Pubitemid 351992081)
24. S. Yamamoto, S. Morinobu, Y. Iwamoto, Y. Ueda, S. Takei, Y. Fujita Alterations in the hippocampal glycinergic system in an animal model of posttraumatic stress disorder J Psychiatr Res 44 2010 1069 1074
25. U. Heresco-Levy, I. Kremer, D.C. Javitt, R. Goichman, A. Reshef, M. Blanaru Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder Int J Neuropsychopharmacol 5 2002 301 307 (Pubitemid 35470350)
26. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 2000 American Psychiatric Press Washington, DC
27. D.V. Sheehan, Y. Lecrubier, K. Sheehan, P. Amorim, J. Janavs, E. Weiller The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 Suppl 20 1998 22 33 (Pubitemid 29001829)
28. D.D. Blake, F.W. Weathers, L.M. Nagy, D.G. Kaloupek The development of a clinician-administered PTSD scale J Trauma Stress 8 1995 75 90
29. D.D. Blake, F.W. Weathers, L.M. Nagy, D.G. Kaloupek, G. Klauminzer, D.S. Charney A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1 The Behavior Therapist 13 1990 187 188
30. E.B. Foa, D.S. Riggs, C.V. Dancu, B.O. Rothbaum Reliability and validity of a brief instrument for assessing post-traumatic stress disorder J Trauma Stress 6 1993 459 473 (Pubitemid 24208473)
31. S.L. Mol, A. Arntz, J.F.M. Metsemakers, G.J. Dinant, P.a.P. Vilters-Van Montfort, J.A. Knottnerus Symptoms of post-traumatic stress disorder after non-traumatic events: evidence from an open population study Br J Psychiatry 186 2005 494 499 (Pubitemid 40834869)
32. C.D. Spielberger, R.L. Gorsuch, R.E. Lushene Manual for the State-Trait Anxiety Inventory 1970 Consulting Psychologists Press Palo Alto, CA
33. H.M. Van Der Ploeg, P.B. Defares, C.D. Spielberger Handleiding bij de Zelf-Beoordelings Vragenlijst ZBV [Manual for the Dutch Version of the Spielberger State-Trait Anxiety Inventory] 1980 Swets and Zeitlinger Lisse 243 249
34. A. Beck, C. Ward, M. Mendelson, J. Mock, J. Erbaugh An inventory for measuring depression Arch Gen Psychiatry 4 1961 561 571
35. A.T. Beck, R.A. Steer, M.G. Garbin Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation Clin Psychol Rev 8 1988 77 100 (Pubitemid 18045797)
36. W.A. Arrindell, J.H.M. Ettema Klachtenlijst (SCL-90) 1986 Swets and Zeitlinger Lisse
37. L.R. Derogatis, K. Rickels, A.F. Rock The SCL-90 and the MMPI: A step in the validation of a new self-report scale Br J Psychiatry 128 1976 280 289
38. J. Hardman, L. Limbird Goodman & Gilman's Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw Hill New York
39. A. Van Minnen, E.B. Foa The effect of imaginal exposure length on outcome of treatment for PTSD J Trauma Stress 19 2006 427 438 (Pubitemid 46422021)
40. M.A. Hagenaars, A. Van Minnen, KaL Hoogduin The impact of dissociation and depression on the efficacy of prolonged exposure treatment for PTSD Behav Res Ther 48 2010 19 27
41. E.B. Foa, E.A. Hembree, S.P. Cahill, SaM. Rauch, D.S. Riggs, N.C. Feeny Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: Outcome at academic and community clinics J Consult Clin Psychol 73 2005 953 964 (Pubitemid 41643245)
42. R.A. Bryant, M.L. Moulds, R.M. Guthrie, S.T. Dang, J. Mastrodomenico, R.D. Nixon A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder J Consult Clin Psychol 76 2008 695 703
43. F.W. Weathers, T.M. Keane, J.R. Davidson Clinician-Administered PTSD Scale: A review of the first ten years of research Depress Anxiety 13 2001 132 156 (Pubitemid 32467173)
44. A. Van Minnen, A. Arntz, G.P.J. Keijsers Prolonged exposure in patients with chronic PTSD: Predictors of treatment outcome and dropout Behav Res Ther 40 2002 439 457 (Pubitemid 34226603)
45. D. Quartermain, J. Mower, M.F. Rafferty, R.L. Herting, T.H. Lanthorn Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention Eur J Pharmacol 257 1994 7 12 (Pubitemid 24178543)
46. A. Guastella, M. Dadds, P. Lovibond, P. Mitchell, R. Richardson A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear J Psychiatr Res 41 2007 466 471 (Pubitemid 46227445)
47. R. Gueorguieva, J.H. Krystal Move over ANOVA: Progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry Arch Gen Psychiatry 61 2004 310 317 (Pubitemid 38295833)